<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">
<pdf2xml producer="poppler" version="23.04.0">
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="font0" size="9" family="Frutiger-UltraBlack,Bold" color="#4e67ad"/>
	<fontspec id="font1" size="9" family="Frutiger-UltraBlack,Bold" color="#007682"/>
	<fontspec id="font2" size="9" family="Courier" color="#007682"/>
	<fontspec id="font3" size="9" family="Frutiger-Light" color="#000000"/>
	<fontspec id="font4" size="9" family="Arial" color="#000000"/>
	<fontspec id="font5" size="7" family="Arial,Italic" color="#000000"/>
	<fontspec id="font6" size="24" family="Frutiger-UltraBlack,Bold" color="#000000"/>
	<fontspec id="font7" size="11" family="Helvetica-Black,Bold" color="#ffffff"/>
	<fontspec id="font8" size="14" family="GillSans-Light" color="#000000"/>
	<fontspec id="font9" size="16" family="GillSans,Bold" color="#000000"/>
	<fontspec id="font10" size="15" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font11" size="11" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font12" size="8" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font13" size="6" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font14" size="11" family="GillSans,Bold" color="#000000"/>
	<fontspec id="font15" size="10" family="GillSans,Bold" color="#000000"/>
	<fontspec id="font16" size="10" family="GillSans" color="#000000"/>
	<fontspec id="font17" size="10" family="GillSans,Italic" color="#000000"/>
	<fontspec id="font18" size="10" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font19" size="8" family="GillSans" color="#000000"/>
	<fontspec id="font20" size="8" family="GillSans,Italic" color="#000000"/>
	<fontspec id="font21" size="8" family="GillSans,Bold" color="#000000"/>
<text top="44" left="508" width="67" height="9" font="font0" id="p1_t1" reading_order_no="1" segment_no="1" tag_type="title">Bio Med Central<a href="http://www.biomedcentral.com/"><b>Bio</b></a></text>
<text top="756" left="503" width="51" height="10" font="font4" id="p1_t2" reading_order_no="51" segment_no="23" tag_type="text">Page 1 of 11<a href="http://www.biomedcentral.com/"><b>Med</b></a></text>
<text top="769" left="432" width="122" height="8" font="font5" id="p1_t3" reading_order_no="52" segment_no="24" tag_type="text">(page number not for citation purposes)<a href="http://www.biomedcentral.com/">Central</a></text>
<text top="35" left="55" width="218" height="23" font="font6" id="p1_t4" reading_order_no="0" segment_no="0" tag_type="title">Virology Journal</text>
<text top="86" left="502" width="79" height="10" font="font7" id="p1_t5" reading_order_no="2" segment_no="2" tag_type="title">Open Access<i>(page number not for citation purposes)</i></text>
<text top="87" left="55" width="50" height="13" font="font8" id="p1_t6" reading_order_no="3" segment_no="3" tag_type="title">Research<b>Virology Journal</b></text>
<text top="105" left="55" width="421" height="15" font="font9" id="p1_t7" reading_order_no="4" segment_no="4" tag_type="title">Small interfering RNA targeted to stem-loop II of the 5'<a href="http://www.biomedcentral.com/info/about/charter/"><b>Open Access</b></a></text>
<text top="123" left="55" width="459" height="15" font="font9" id="p1_t8" reading_order_no="5" segment_no="4" tag_type="title">untranslated region effectively inhibits expression of six HCV</text>
<text top="141" left="55" width="76" height="15" font="font9" id="p1_t9" reading_order_no="6" segment_no="4" tag_type="title">genotypes<b>Small interfering RNA targeted to stem-loop II of the 5' </b></text>
<text top="158" left="55" width="354" height="14" font="font10" id="p1_t10" reading_order_no="7" segment_no="5" tag_type="text">Ramesh Prabhu 1 , Robert F Garry 2 and Srikanta Dash* 1<b>untranslated region effectively inhibits expression of six HCV </b></text>
<text top="193" left="55" width="497" height="9" font="font12" id="p1_t11" reading_order_no="8" segment_no="6" tag_type="text">Address: 1 Department of Pathology and Laboratory Medicine, Tulane University Health Sciences Center, 1430 Tulane Avenue, New Orleans, LA-<b>genotypes</b></text>
<text top="203" left="55" width="499" height="8" font="font12" id="p1_t12" reading_order_no="9" segment_no="6" tag_type="text">70112, USA and 2 Department of Microbiology and Immunology, Tulane University Health Sciences Center, 1430 Tulane Avenue, New Orleans,</text>
<text top="213" left="55" width="53" height="8" font="font12" id="p1_t13" reading_order_no="10" segment_no="6" tag_type="text">LA-70112, USA</text>
<text top="227" left="55" width="414" height="8" font="font12" id="p1_t14" reading_order_no="11" segment_no="7" tag_type="text">Email: Ramesh Prabhu - rprabhu@tulane.edu; Robert F Garry - rfgarry@tulane.edu; Srikanta Dash* - sdash@tulane.edu</text>
<text top="239" left="55" width="92" height="8" font="font12" id="p1_t15" reading_order_no="12" segment_no="8" tag_type="text">* Corresponding author</text>
<text top="387" left="112" width="44" height="10" font="font14" id="p1_t16" reading_order_no="22" segment_no="16" tag_type="title">Abstract</text>
<text top="402" left="112" width="386" height="9" font="font15" id="p1_t17" reading_order_no="23" segment_no="17" tag_type="text">Background: The antiviral action of interferon alpha targets the 5' untranslated region (UTR)</text>
<text top="413" left="112" width="385" height="9" font="font16" id="p1_t18" reading_order_no="24" segment_no="17" tag_type="text">used by hepatitis C virus (HCV) to translate protein by an internal ribosome entry site (IRES)</text>
<text top="425" left="112" width="385" height="9" font="font16" id="p1_t19" reading_order_no="25" segment_no="17" tag_type="text">mechanism. Although this sequence is highly conserved among different clinical strains,</text>
<text top="437" left="112" width="386" height="9" font="font16" id="p1_t20" reading_order_no="26" segment_no="17" tag_type="text">approximately half of chronically infected hepatitis C patients do not respond to interferon therapy.</text>
<text top="449" left="112" width="386" height="9" font="font16" id="p1_t21" reading_order_no="27" segment_no="17" tag_type="text">Therefore, development of small interfering RNA (siRNA) targeted to the 5'UTR to inhibit IRES</text>
<text top="460" left="112" width="386" height="9" font="font16" id="p1_t22" reading_order_no="28" segment_no="17" tag_type="text">mediated translation may represent an alternative approach that could circumvent the problem of</text>
<text top="472" left="112" width="84" height="9" font="font16" id="p1_t23" reading_order_no="29" segment_no="17" tag_type="text">interferon resistance.</text>
<text top="489" left="112" width="385" height="9" font="font15" id="p1_t24" reading_order_no="30" segment_no="18" tag_type="text">Results: Four different plasmid constructs were prepared for intracellular delivery of siRNAs</text>
<text top="501" left="112" width="386" height="9" font="font16" id="p1_t25" reading_order_no="31" segment_no="18" tag_type="text">targeting the stem loop II-III of HCV 5' UTR. The effect of siRNA production on IRES mediated</text>
<text top="512" left="112" width="386" height="9" font="font16" id="p1_t26" reading_order_no="32" segment_no="18" tag_type="text">translation was investigated using chimeric clones between the gene for green fluorescence protein<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=17129382">  </a></text>
<text top="524" left="112" width="386" height="9" font="font16" id="p1_t27" reading_order_no="33" segment_no="18" tag_type="text">(GFP) and IRES sequences of six different HCV genotypes. The siRNA targeted to stem loop II<b>Abstract</b></text>
<text top="536" left="112" width="385" height="9" font="font16" id="p1_t28" reading_order_no="34" segment_no="18" tag_type="text">effectively mediated degradation of HCV IRES mRNA and inhibited GFP expression in the case of<b>Background: </b></text>
<text top="548" left="112" width="386" height="9" font="font16" id="p1_t29" reading_order_no="35" segment_no="18" tag_type="text">six different HCV genotypes, where as  siRNAs  targeted  to  stem  loop  III  did  not.  Furthermore,</text>
<text top="559" left="112" width="386" height="9" font="font16" id="p1_t30" reading_order_no="36" segment_no="18" tag_type="text">intracytoplasmic expression of siRNA into transfected Huh-7 cells efficiently degraded HCV</text>
<text top="571" left="112" width="385" height="9" font="font16" id="p1_t31" reading_order_no="37" segment_no="18" tag_type="text">genomic RNA and inhibited core protein expression from infectious full-length infectious clones</text>
<text top="583" left="112" width="114" height="9" font="font16" id="p1_t32" reading_order_no="38" segment_no="18" tag_type="text">HCV 1a and HCV 1b strains.</text>
<text top="600" left="112" width="386" height="9" font="font15" id="p1_t33" reading_order_no="39" segment_no="19" tag_type="text">Conclusion: These in vitro studies suggest that siRNA targeted to stem-loop II is highly effective</text>
<text top="611" left="112" width="386" height="9" font="font16" id="p1_t34" reading_order_no="40" segment_no="19" tag_type="text">inhibiting IRES mediated translation of the major genotypes of HCV. Stem-loop II siRNA may be a</text>
<text top="623" left="112" width="386" height="9" font="font16" id="p1_t35" reading_order_no="41" segment_no="19" tag_type="text">good target for developing an intracellular immunization strategy based antiviral therapy to inhibit</text>
<text top="635" left="112" width="236" height="9" font="font16" id="p1_t36" reading_order_no="42" segment_no="19" tag_type="text">hepatitis C virus strains that are not inhibited by interferon.<b>Results: </b></text>
<text top="684" left="55" width="60" height="10" font="font14" id="p1_t37" reading_order_no="43" segment_no="20" tag_type="title">Background</text>
<text top="696" left="55" width="241" height="9" font="font18" id="p1_t38" reading_order_no="44" segment_no="22" tag_type="text">Hepatitis C virus (HCV) is a major blood-borne human</text>
<text top="707" left="55" width="241" height="9" font="font18" id="p1_t39" reading_order_no="45" segment_no="22" tag_type="text">pathogen [1]. It is estimated that more than 170 million</text>
<text top="719" left="55" width="241" height="9" font="font18" id="p1_t40" reading_order_no="46" segment_no="22" tag_type="text">people worldwide have been infected with hepatitis C [2].</text>
<text top="684" left="313" width="241" height="9" font="font18" id="p1_t41" reading_order_no="47" segment_no="21" tag_type="text">The majority of infected individuals develop life long</text>
<text top="696" left="313" width="241" height="9" font="font18" id="p1_t42" reading_order_no="48" segment_no="21" tag_type="text">chronic infections since only a fraction of people infected</text>
<text top="707" left="313" width="241" height="9" font="font18" id="p1_t43" reading_order_no="49" segment_no="21" tag_type="text">with HCV develop immunity and clear the virus infection</text>
<text top="719" left="313" width="241" height="9" font="font18" id="p1_t44" reading_order_no="50" segment_no="21" tag_type="text">[3]. Chronic hepatitis C virus infection can results in long-</text>
<text top="281" left="55" width="98" height="7" font="font19" id="p1_t45" reading_order_no="13" segment_no="9" tag_type="text">Published: 27 November 2006</text>
<text top="296" left="55" width="87" height="7" font="font20" id="p1_t46" reading_order_no="14" segment_no="12" tag_type="text">Virology Journal 2006, 3 :100<b>Conclusion: </b></text>
<text top="296" left="150" width="97" height="7" font="font19" id="p1_t47" reading_order_no="15" segment_no="12" tag_type="text">doi:10.1186/1743-422X-3-100</text>
<text top="281" left="310" width="90" height="7" font="font19" id="p1_t48" reading_order_no="20" segment_no="10" tag_type="text">Received: 23 October 2006<i>in vitro </i></text>
<text top="291" left="310" width="98" height="7" font="font19" id="p1_t49" reading_order_no="21" segment_no="11" tag_type="text">Accepted: 27 November 2006</text>
<text top="310" left="55" width="230" height="7" font="font19" id="p1_t50" reading_order_no="16" segment_no="13" tag_type="text">This article is available from: http://www.virologyj.com/content/3/1/100</text>
<text top="324" left="55" width="165" height="7" font="font19" id="p1_t51" reading_order_no="17" segment_no="14" tag_type="text">Â© 2006 Prabhu et al; licensee BioMed Central Ltd.</text>
<text top="333" left="55" width="492" height="7" font="font19" id="p1_t52" reading_order_no="18" segment_no="15" tag_type="text">This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0),</text>
<text top="343" left="55" width="400" height="7" font="font19" id="p1_t53" reading_order_no="19" segment_no="15" tag_type="text">which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.<b>Background</b></text>
</page>
</pdf2xml>
